INVO Bioscience Q1 EPS $(0.42), Sales $1.58M Up From $348.02K YoY
Portfolio Pulse from Benzinga Newsdesk
INVO Bioscience (NASDAQ:INVO) reported a Q1 EPS loss of $(0.42) and sales of $1.58 million, marking a 352.84% increase from the same period last year.
May 15, 2024 | 8:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
INVO Bioscience reported a Q1 EPS loss of $(0.42) and a significant increase in sales to $1.58 million, up 352.84% YoY.
Despite the EPS loss, the substantial increase in sales indicates strong revenue growth, which is likely to positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100